CA3018035A1 - Composition bacterienne d'acide lactique pour le traitement d'infections vaginales bacteriennes par gardnerella vaginalis et, eventuellement, d'infections fongiques concurrentes - Google Patents

Composition bacterienne d'acide lactique pour le traitement d'infections vaginales bacteriennes par gardnerella vaginalis et, eventuellement, d'infections fongiques concurrentes Download PDF

Info

Publication number
CA3018035A1
CA3018035A1 CA3018035A CA3018035A CA3018035A1 CA 3018035 A1 CA3018035 A1 CA 3018035A1 CA 3018035 A CA3018035 A CA 3018035A CA 3018035 A CA3018035 A CA 3018035A CA 3018035 A1 CA3018035 A1 CA 3018035A1
Authority
CA
Canada
Prior art keywords
composition
vaginal
fermentum
candida
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3018035A
Other languages
English (en)
Inventor
Giovanni Mogna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probiotical SpA
Original Assignee
Probiotical SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical SpA filed Critical Probiotical SpA
Publication of CA3018035A1 publication Critical patent/CA3018035A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition pharmaceutique ou une composition pour un dispositif médical ou une composition pour un supplément alimentaire (en bref, la ou les composition(s) de la présente invention) basée(s) sur des bactéries lactiques appartenant à l'espèce Lactobacillus fermentum pour une utilisation vaginale et orale pour le traitement simultané d'infections vaginales, de troubles ou de maladies d'origine fongique et bactérienne. Spécifiquement, la présente invention concerne une composition comprenant des excipients de qualité pharmaceutique et/ou alimentaire et un mélange, qui comprend ou, en variante, est constitué d'au moins une souche de bactéries appartenant à l'espèce Lactobacillus fermentum pour une utilisation vaginale et orale pour le traitement simultané d'infections vaginales, de troubles ou de maladies sélectionnés parmi la candidose, la vaginite, la vulvovaginite ou la vaginose bactérienne.
CA3018035A 2016-03-24 2017-03-24 Composition bacterienne d'acide lactique pour le traitement d'infections vaginales bacteriennes par gardnerella vaginalis et, eventuellement, d'infections fongiques concurrentes Abandoned CA3018035A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUA20162013 2016-03-24
IT102016000031269 2016-03-24
PCT/IB2017/051710 WO2017163216A1 (fr) 2016-03-24 2017-03-24 Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes

Publications (1)

Publication Number Publication Date
CA3018035A1 true CA3018035A1 (fr) 2017-09-28

Family

ID=59899113

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3018035A Abandoned CA3018035A1 (fr) 2016-03-24 2017-03-24 Composition bacterienne d'acide lactique pour le traitement d'infections vaginales bacteriennes par gardnerella vaginalis et, eventuellement, d'infections fongiques concurrentes

Country Status (3)

Country Link
BR (1) BR112018068466A2 (fr)
CA (1) CA3018035A1 (fr)
WO (1) WO2017163216A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3818985A1 (fr) 2019-11-06 2021-05-12 Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Lactobacillus fermentum pl9 et son application

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
CN110540945B (zh) * 2018-05-29 2023-04-25 广东强基药业有限公司 一种詹氏乳杆菌及其用于制备阴道抑菌药物的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210465B1 (pl) * 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
EP2158916A1 (fr) * 2008-08-27 2010-03-03 Ellen Aktiebolag Unité d'administration contenant des bactéries produisant de l'acide lactique
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
WO2013093941A2 (fr) * 2011-12-21 2013-06-27 Talwar Research Foundation Compositions comprenant des souches de lactobacilles probiotiques pour améliorer l'hygiène vaginale
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3818985A1 (fr) 2019-11-06 2021-05-12 Sanprobi Spolka Z Ograniczona Odpowiedzialnoscia Spolka Lactobacillus fermentum pl9 et son application

Also Published As

Publication number Publication date
BR112018068466A2 (pt) 2019-01-22
WO2017163216A1 (fr) 2017-09-28

Similar Documents

Publication Publication Date Title
US20210023150A1 (en) Lactic acid bacterial composition for the treatment of bacterial vaginal infections by gardnerella vaginalis and, if present, of concurrent fungal infections
JP4455333B2 (ja) プロバイオティック細菌：Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ
EP2996701B1 (fr) Composition contenant des bacteries d'acide lactique pour son utilisation dans le traitement preventif et/ou curatif de la vaginose bactérienne
EP3193895B1 (fr) Souche inducia dsm 21379 de lactobacillus plantarum utilisée comme agent hypocholestérolémique et agent antimicrobien dirigé contre clostridium difficile
US8846027B2 (en) Compositions for the vaginal and oral administration of Lactobacillus and uses thereof
EP3139939B1 (fr) Compositions et méthodes de traitement de maladies de la peau et des muqueuses
KR101757504B1 (ko) 경구용 피부 성상 개선제
US20150190438A1 (en) Novel strain of lactobacillus crispatus
KR20040111434A (ko) 유산균을 유효성분으로 하는 생균제제 및 유산균 함유 식품
RU2536264C2 (ru) Композиция для наружного применения на коже, содержащая соль и сахар в качестве активных ингредиентов, для предотвращения и лечения вагиноза, и ее применение
JP6839329B2 (ja) ヘリコバクター・ピロリ感染症の管理のための組成物
KR101860513B1 (ko) 질에서 분리한 락토바실러스 살리바리우스 mg242를 포함하는 칸디다성 질염의 예방 또는 치료용 조성물
WO2005030230A1 (fr) Compositions et methodes permettant de traiter ou de prevenir le psoriasis et des troubles correspondant
CA3018035A1 (fr) Composition bacterienne d'acide lactique pour le traitement d'infections vaginales bacteriennes par gardnerella vaginalis et, eventuellement, d'infections fongiques concurrentes
Nwaokorie et al. Antimicrobial activities of Garcinia kola on oral Fusobacterium nucleatum and biofilm
FI113057B (fi) Menetelmä hiivojen kasvun estämiseksi
JP2024503366A (ja) 菌株、組成物および使用方法
KR20190102498A (ko) 질염 원인균에 대한 증식억제활성을 갖는 락토바실러스 속 균주 조합 및 이를 유효성분으로 함유하는 제품
KR20220109667A (ko) 파골 세포(Osteoclast) 분화 억제 효과를 갖는 락토바실러스 플란타럼 및 이의 용도
RU2732244C2 (ru) Композиции для лечения кандидозных инфекций
US20240050493A1 (en) Strains, compositions and methods of use
CN116024128B (zh) 一株嗜热链球菌菌株p0012及其制备的口腔健康护理用益生菌组合物和应用
US20230218666A1 (en) Antimicrobial combinations
US20220233618A1 (en) Composition containing a yeast for preventing simple and/or recurring cystitis
CN117062614A (zh) 菌株、组合物和使用方法

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20230621